Sveriges mest populära poddar
Research To Practice | Oncology Videos
Hälsa och motionMedicin

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

1 tim 30 min•2 juli 2026

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:

  • Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)
  • Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)
  • Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)
  • Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55)
  • Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20)

NCPD information and select publications

Fler avsnitt av Research To Practice | Oncology Videos

Visa alla avsnitt av Research To Practice | Oncology Videos
Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
•50 min
HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit
•1 tim 39 min
Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit
•52 min
Desmoid Tumors and Soft Tissue Sarcoma — Fifth Annual National General Medical Oncology Summit
•51 min
EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
•51 min
Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know
•54 min
Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD
•24 min
Urothelial Bladder Cancer | Ashish M Kamat, MD, MBBS
•19 min
Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
•1 tim 28 min

Research To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.